Global Hemophilia Drugs Market Research Report 2016

October 2016 | 103 pages | ID: G3BC2B84EEFEN
QYResearch

Abstracts

Notes:

Production, means the output of Hemophilia Drugs

Revenue, means the sales value of Hemophilia Drugs

This report studies Hemophilia Drugs in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering

• Baxalta
• Bayer
• CSL Behring
• Novo Nordisk
• Pfizer
• Roche
• Alnylam Pharmaceuticals
• Amarna Therapeutics
• Asklepios BioPharmaceutical
• Biogen
• BioMarin
• Catalyst Bioscience
• Chiesi Farmaceutici
• Dimension Therapeutics
• Emergent BioSolutions
• Grifols, Kedrion Biopharma
• Octapharma
• rEVO Biologics
• OPKO Biologics
• Sangamo Biosciences
• Spark Therapeutics
• Swedish Orphan Biovitrum
• UniQure Biopharma.

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Hemophilia Drugs in these regions, from 2011 to 2021 (forecast), like

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by application, this report focuses on consumption, market share and growth rate of Hemophilia Drugs in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Global Hemophilia Drugs Market Research Report 2016

1 HEMOPHILIA DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Hemophilia Drugs
1.2 Hemophilia Drugs Segment by Type
  1.2.1 Global Production Market Share of Hemophilia Drugs by Type in 2015
  1.2.2 Type I
  1.2.3 Type II
  1.2.4 Type III
1.3 Hemophilia Drugs Segment by Application
  1.3.1 Hemophilia Drugs Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Hemophilia Drugs Market by Region
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 Europe Status and Prospect (2011-2021)
  1.4.3 China Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 Southeast Asia Status and Prospect (2011-2021)
  1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Hemophilia Drugs (2011-2021)

2 GLOBAL HEMOPHILIA DRUGS MARKET COMPETITION BY MANUFACTURERS

2.1 Global Hemophilia Drugs Production and Share by Manufacturers (2015 and 2016)
2.2 Global Hemophilia Drugs Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Hemophilia Drugs Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Hemophilia Drugs Manufacturing Base Distribution, Sales Area and Product Type
2.5 Hemophilia Drugs Market Competitive Situation and Trends
  2.5.1 Hemophilia Drugs Market Concentration Rate
  2.5.2 Hemophilia Drugs Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL HEMOPHILIA DRUGS PRODUCTION, REVENUE (VALUE) BY REGION (2011-2016)

3.1 Global Hemophilia Drugs Production and Market Share by Region (2011-2016)
3.2 Global Hemophilia Drugs Revenue (Value) and Market Share by Region (2011-2016)
3.3 Global Hemophilia Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.4 North America Hemophilia Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.5 Europe Hemophilia Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.6 China Hemophilia Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.7 Japan Hemophilia Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Southeast Asia Hemophilia Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.9 India Hemophilia Drugs Production, Revenue, Price and Gross Margin (2011-2016)

4 GLOBAL HEMOPHILIA DRUGS SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2011-2016)

4.1 Global Hemophilia Drugs Consumption by Regions (2011-2016)
4.2 North America Hemophilia Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Hemophilia Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Hemophilia Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Hemophilia Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia Hemophilia Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Hemophilia Drugs Production, Consumption, Export, Import by Regions (2011-2016)

5 GLOBAL HEMOPHILIA DRUGS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Hemophilia Drugs Production and Market Share by Type (2011-2016)
5.2 Global Hemophilia Drugs Revenue and Market Share by Type (2011-2016)
5.3 Global Hemophilia Drugs Price by Type (2011-2016)
5.4 Global Hemophilia Drugs Production Growth by Type (2011-2016)

6 GLOBAL HEMOPHILIA DRUGS MARKET ANALYSIS BY APPLICATION

6.1 Global Hemophilia Drugs Consumption and Market Share by Application (2011-2016)
6.2 Global Hemophilia Drugs Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL HEMOPHILIA DRUGS MANUFACTURERS PROFILES/ANALYSIS

7.1 Baxalta
  7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.1.2 Hemophilia Drugs Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 Baxalta Hemophilia Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.1.4 Main Business/Business Overview
7.2 Bayer
  7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.2.2 Hemophilia Drugs Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 Bayer Hemophilia Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.2.4 Main Business/Business Overview
7.3 CSL Behring
  7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.3.2 Hemophilia Drugs Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 CSL Behring Hemophilia Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.3.4 Main Business/Business Overview
7.4 Novo Nordisk
  7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.4.2 Hemophilia Drugs Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 Novo Nordisk Hemophilia Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.4.4 Main Business/Business Overview
7.5 Pfizer
  7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.5.2 Hemophilia Drugs Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 Pfizer Hemophilia Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.5.4 Main Business/Business Overview
7.6 Roche
  7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.6.2 Hemophilia Drugs Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 Roche Hemophilia Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.6.4 Main Business/Business Overview
7.7 Alnylam Pharmaceuticals
  7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.7.2 Hemophilia Drugs Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
  7.7.3 Alnylam Pharmaceuticals Hemophilia Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.7.4 Main Business/Business Overview
7.8 Amarna Therapeutics
  7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.8.2 Hemophilia Drugs Product Type, Application and Specification
    7.8.2.1 Type I
    7.8.2.2 Type II
  7.8.3 Amarna Therapeutics Hemophilia Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.8.4 Main Business/Business Overview
7.9 Asklepios BioPharmaceutical
  7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.9.2 Hemophilia Drugs Product Type, Application and Specification
    7.9.2.1 Type I
    7.9.2.2 Type II
  7.9.3 Asklepios BioPharmaceutical Hemophilia Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.9.4 Main Business/Business Overview
7.10 Biogen
  7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.10.2 Hemophilia Drugs Product Type, Application and Specification
    7.10.2.1 Type I
    7.10.2.2 Type II
  7.10.3 Biogen Hemophilia Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.10.4 Main Business/Business Overview
7.11 BioMarin
7.12 Catalyst Bioscience
7.13 Chiesi Farmaceutici
7.14 Dimension Therapeutics
7.15 Emergent BioSolutions
7.16 Grifols, Kedrion Biopharma
7.17 Octapharma
7.18 rEVO Biologics
7.19 OPKO Biologics
7.20 Sangamo Biosciences
7.21 Spark Therapeutics
7.22 Swedish Orphan Biovitrum
7.23 UniQure Biopharma.

8 HEMOPHILIA DRUGS MANUFACTURING COST ANALYSIS

8.1 Hemophilia Drugs Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Hemophilia Drugs

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Hemophilia Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Hemophilia Drugs Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL HEMOPHILIA DRUGS MARKET FORECAST (2016-2021)

12.1 Global Hemophilia Drugs Production, Revenue Forecast (2016-2021)
12.2 Global Hemophilia Drugs Production, Consumption Forecast by Regions (2016-2021)
12.3 Global Hemophilia Drugs Production Forecast by Type (2016-2021)
12.4 Global Hemophilia Drugs Consumption Forecast by Application (2016-2021)
12.5 Hemophilia Drugs Price Forecast (2016-2021)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Hemophilia Drugs
Figure Global Production Market Share of Hemophilia Drugs by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table Hemophilia Drugs Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Application 3 Examples
Figure North America Hemophilia Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Hemophilia Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Hemophilia Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Hemophilia Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia Hemophilia Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure India Hemophilia Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global Hemophilia Drugs Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global Hemophilia Drugs Production of Key Manufacturers (2015 and 2016)
Table Global Hemophilia Drugs Production Share by Manufacturers (2015 and 2016)
Figure 2015 Hemophilia Drugs Production Share by Manufacturers
Figure 2016 Hemophilia Drugs Production Share by Manufacturers
Table Global Hemophilia Drugs Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Hemophilia Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Hemophilia Drugs Revenue Share by Manufacturers
Table 2016 Global Hemophilia Drugs Revenue Share by Manufacturers
Table Global Market Hemophilia Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Hemophilia Drugs Average Price of Key Manufacturers in 2015
Table Manufacturers Hemophilia Drugs Manufacturing Base Distribution and Sales Area
Table Manufacturers Hemophilia Drugs Product Type
Figure Hemophilia Drugs Market Share of Top 3 Manufacturers
Figure Hemophilia Drugs Market Share of Top 5 Manufacturers
Table Global Hemophilia Drugs Production by Regions (2011-2016)
Figure Global Hemophilia Drugs Production and Market Share by Regions (2011-2016)
Figure Global Hemophilia Drugs Production Market Share by Regions (2011-2016)
Figure 2015 Global Hemophilia Drugs Production Market Share by Regions
Table Global Hemophilia Drugs Revenue by Regions (2011-2016)
Table Global Hemophilia Drugs Revenue Market Share by Regions (2011-2016)
Table 2015 Global Hemophilia Drugs Revenue Market Share by Regions
Table Global Hemophilia Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Hemophilia Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Hemophilia Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table China Hemophilia Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Hemophilia Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia Hemophilia Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table India Hemophilia Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Hemophilia Drugs Consumption Market by Regions (2011-2016)
Table Global Hemophilia Drugs Consumption Market Share by Regions (2011-2016)
Figure Global Hemophilia Drugs Consumption Market Share by Regions (2011-2016)
Figure 2015 Global Hemophilia Drugs Consumption Market Share by Regions
Table North America Hemophilia Drugs Production, Consumption, Import & Export (2011-2016)
Table Europe Hemophilia Drugs Production, Consumption, Import & Export (2011-2016)
Table China Hemophilia Drugs Production, Consumption, Import & Export (2011-2016)
Table Japan Hemophilia Drugs Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia Hemophilia Drugs Production, Consumption, Import & Export (2011-2016)
Table India Hemophilia Drugs Production, Consumption, Import & Export (2011-2016)
Table Global Hemophilia Drugs Production by Type (2011-2016)
Table Global Hemophilia Drugs Production Share by Type (2011-2016)
Figure Production Market Share of Hemophilia Drugs by Type (2011-2016)
Figure 2015 Production Market Share of Hemophilia Drugs by Type
Table Global Hemophilia Drugs Revenue by Type (2011-2016)
Table Global Hemophilia Drugs Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Hemophilia Drugs by Type (2011-2016)
Figure 2015 Revenue Market Share of Hemophilia Drugs by Type
Table Global Hemophilia Drugs Price by Type (2011-2016)
Figure Global Hemophilia Drugs Production Growth by Type (2011-2016)
Table Global Hemophilia Drugs Consumption by Application (2011-2016)
Table Global Hemophilia Drugs Consumption Market Share by Application (2011-2016)
Figure Global Hemophilia Drugs Consumption Market Share by Application in 2015
Table Global Hemophilia Drugs Consumption Growth Rate by Application (2011-2016)
Figure Global Hemophilia Drugs Consumption Growth Rate by Application (2011-2016)
Table Baxalta Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Baxalta Hemophilia Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Baxalta Hemophilia Drugs Market Share (2011-2016)
Table Bayer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer Hemophilia Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Bayer Hemophilia Drugs Market Share (2011-2016)
Table CSL Behring Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table CSL Behring Hemophilia Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure CSL Behring Hemophilia Drugs Market Share (2011-2016)
Table Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novo Nordisk Hemophilia Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Novo Nordisk Hemophilia Drugs Market Share (2011-2016)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Hemophilia Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Hemophilia Drugs Market Share (2011-2016)
Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Hemophilia Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Roche Hemophilia Drugs Market Share (2011-2016)
Table Alnylam Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Alnylam Pharmaceuticals Hemophilia Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Alnylam Pharmaceuticals Hemophilia Drugs Market Share (2011-2016)
Table Amarna Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Amarna Therapeutics Hemophilia Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Amarna Therapeutics Hemophilia Drugs Market Share (2011-2016)
Table Asklepios BioPharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Asklepios BioPharmaceutical Hemophilia Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Asklepios BioPharmaceutical Hemophilia Drugs Market Share (2011-2016)
Table Biogen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Biogen Hemophilia Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Biogen Hemophilia Drugs Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Hemophilia Drugs
Figure Manufacturing Process Analysis of Hemophilia Drugs
Figure Hemophilia Drugs Industrial Chain Analysis
Table Raw Materials Sources of Hemophilia Drugs Major Manufacturers in 2015
Table Major Buyers of Hemophilia Drugs
Table Distributors/Traders List
Figure Global Hemophilia Drugs Production and Growth Rate Forecast (2016-2021)
Figure Global Hemophilia Drugs Revenue and Growth Rate Forecast (2016-2021)
Table Global Hemophilia Drugs Production Forecast by Regions (2016-2021)
Table Global Hemophilia Drugs Consumption Forecast by Regions (2016-2021)
Table Global Hemophilia Drugs Production Forecast by Type (2016-2021)
Table Global Hemophilia Drugs Consumption Forecast by Application (2016-2021)